Therapy area
Oncology
ATC groups L01, L02
- Molecules
- 275
- Current shortages
- 0
Cancer medicines, including chemotherapy, targeted therapies, monoclonal antibodies and hormonal treatments, supplied for hospitals and named patients.
Molecules
275 molecules, most requested first.
- CelecoxibAnti-Inflammatory Agents10 presentations3 brandsL01XX33
- TemozolomideOrphanAlkylating Drug13 presentations6 brandsL01AX03
- EverolimusOrphanKinase Inhibitor30 presentations7 brandsL01XE10
- TretinoinOrphanRetinoid24 presentations6 brandsD10AD01
- DasatinibOrphanKinase Inhibitor18 presentations4 brandsL01EA02
- MethotrexateOrphanFolate Analog Metabolic Inhibitor28 presentations7 brandsL01BA01
- DocetaxelMicrotubule Inhibitor14 presentations6 brandsL01CD02
- Cyclophosphamide18 presentations1 brandL01AA01
- AnastrozoleAromatase Inhibitor2 presentations1 brandL02BG03
- MedroxyprogesteroneProgestin10 presentations3 brandsG03AC06
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- FluorouracilOrphanNucleoside Metabolic Inhibitor13 presentations3 brandsL01BC02
- ImatinibOrphanKinase Inhibitor5 presentations5 brandsL01EA01
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- OxaliplatinPlatinum-based Drug4 presentationsL01XA03
- AbirateroneCytochrome P450 17A1 Inhibitor7 presentations7 brandsL02BX03
- SunitinibKinase Inhibitor8 presentations3 brandsL01EX01
- CapecitabineNucleoside Metabolic Inhibitor3 presentations6 brandsL01BC06
- GemcitabineNucleoside Metabolic Inhibitor13 presentations2 brandsL01BC05
- MegestrolOrphanProgestin4 presentationsL02AB01
- ErlotinibKinase Inhibitor3 presentations1 brandL01EB02
- BortezomibOrphanProteasome Inhibitor9 presentations6 brandsL01XG01
- IrinotecanOrphanTopoisomerase Inhibitor8 presentations3 brandsL01CE02
- LetrozoleAromatase Inhibitor2 presentations1 brandL02BG04
- NilotinibOrphanKinase Inhibitor10 presentations5 brandsL01EA03
- PemetrexedOrphanFolate Analog Metabolic Inhibitor9 presentations8 brandsL01BA04
- LeuprolideOrphanGonadotropin Releasing Hormone Receptor Agonist23 presentations9 brandsL02AE02
- Arsenic trioxideOrphan4 presentations4 brandsL01XX27
- AzacitidineOrphanNucleoside Metabolic Inhibitor7 presentations8 brandsL01BC07
- CisplatinPlatinum-based Drug5 presentations1 brandL01XA01
- NintedanibOrphanKinase Inhibitor4 presentations5 brandsL01EX09
- EtoposideTopoisomerase Inhibitor8 presentations3 brandsL01CB01
- HydroxyureaOrphanAntimetabolite10 presentations6 brandsL01XX05
- FulvestrantEstrogen Receptor Antagonist4 presentations4 brandsL02BA03
- TamoxifenEstrogen Agonist/Antagonist3 presentations1 brandL02BA01
- DecitabineOrphanNucleoside Metabolic Inhibitor5 presentationsL01BC08
- CladribinePurine Antimetabolite4 presentations3 brandsL01BB04
- NelarabineOrphanNucleoside Metabolic Inhibitor3 presentations2 brandsL01BB07
- ThiotepaOrphanAlkylating Drug7 presentations2 brandsL01AC01
- EribulinOrphanMicrotubule Inhibitor2 presentations3 brandsL01XX41
- BevacizumabOrphanVascular Endothelial Growth Factor Inhibitor13 presentations17 brandsL01FG01
- TrastuzumabOrphanHER2/neu Receptor Antagonist14 presentations18 brandsL01FD01
- BendamustineOrphanAlkylating Drug9 presentations5 brandsL01AA09
- BicalutamideAndrogen Receptor Inhibitor2 presentations1 brandL02BB03
- AfliberceptOrphanVascular Endothelial Growth Factor Inhibitor8 presentations21 brandsL01XX44
- CytarabineOrphanNucleoside Metabolic Inhibitor5 presentationsL01BC01
- RuxolitinibOrphanJanus Kinase Inhibitor11 presentations6 brandsD11AH09
- LomustineAlkylating Drug6 presentations1 brandL01AD02
- PazopanibOrphanKinase Inhibitor3 presentations2 brandsL01XE11
- TalazoparibPoly(ADP-Ribose) Polymerase Inhibitor9 presentations2 brandsL01XK04
- ExemestaneOrphanAromatase Inhibitor2 presentations1 brandL02BG06
- SorafenibOrphanKinase Inhibitor2 presentations3 brandsL01EX02
- BleomycinCytoprotective Agent2 presentationsL01DC01
- IdarubicinOrphanAnthracycline Topoisomerase Inhibitor6 presentations1 brandL01DB06
- BexaroteneOrphanRetinoid4 presentations2 brandsL01XF03
- BosutinibOrphanKinase Inhibitor8 presentations2 brandsL01EA04
- RituximabOrphanCD20-directed Cytolytic Antibody8 presentations11 brandsL01FA01
- IfosfamideOrphanAlkylating Drug5 presentations1 brandL01AA06
- ClofarabineOrphanNucleoside Metabolic Inhibitor1 presentation1 brandL01BB06
- BusulfanOrphanAlkylating Drug2 presentations2 brandsL01AB01
- TopotecanTopoisomerase Inhibitor5 presentations5 brandsL01CE01
- AnagrelideOrphanPlatelet-reducing Agent3 presentations3 brandsL01XX35
- MitoxantroneTopoisomerase Inhibitor3 presentationsL01DB07
- PalbociclibKinase Inhibitor6 presentations3 brandsL01EF01
- SelinexorOrphanNuclear Export Inhibitor6 presentations2 brandsL01XX66
- AlpelisibOrphan7 presentations4 brandsL01EM03
- MercaptopurineOrphanNucleoside Metabolic Inhibitor2 presentations1 brandL01BB02
- IbrutinibOrphanKinase Inhibitor6 presentations2 brandsL01EL01
- SelpercatinibOrphanKinase Inhibitor6 presentations2 brandsL01EX22
- LarotrectinibOrphanKinase Inhibitor4 presentations3 brandsL01XE53
- DaunorubicinOrphanAnthracycline Topoisomerase Inhibitor2 presentationsL01DB02
- AfatinibOrphanKinase Inhibitor6 presentations2 brandsL01XE13
- PralatrexateOrphanFolate Analog Metabolic Inhibitor4 presentations1 brandL01BA05
- VenetoclaxOrphanBCL-2 Inhibitor4 presentations2 brandsL01XX52
- GefitinibOrphanKinase Inhibitor2 presentations2 brandsL01XE02
- LenvatinibOrphanKinase Inhibitor3 presentations2 brandsL01EX08
- AvapritinibOrphanKinase Inhibitor5 presentations2 brandsL01EX18
- CrizotinibOrphanKinase Inhibitor5 presentations2 brandsL01ED01
- SelumetinibOrphanKinase Inhibitor4 presentations2 brandsL01EE04
- OlaparibOrphanPoly(ADP-Ribose) Polymerase Inhibitor2 presentations2 brandsL01XK01
- BrigatinibOrphanKinase Inhibitor4 presentations2 brandsL01XE43
- PonatinibOrphanKinase Inhibitor4 presentations2 brandsL01EA05
- Aminolevulinic acidOrphanOptical Imaging Agent3 presentations3 brandsL01XD04
- IxazomibOrphanProteasome Inhibitor3 presentations2 brandsL01XG03
- DactinomycinActinomycin2 presentationsL01DA01
- AbemaciclibKinase Inhibitor4 presentations2 brandsL01EF03
- MosunetuzumabOrphan4 presentations3 brandsL01FX25
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- TriptorelinOrphan4 presentations2 brandsL02AE04
- ErdafitinibKinase Inhibitor3 presentations1 brandL01EN01
- MirdametinibOrphanKinase Inhibitor3 presentations2 brandsL01EE
- SotorasibOrphan3 presentations2 brandsL01XX73
- LapatinibKinase Inhibitor2 presentations2 brandsL01EH01
- Tipiracil and TrifluridineOrphanNucleoside Analog2 presentations2 brandsL01BC59
- VinorelbineVinca Alkaloid2 presentationsL01CA04
- Capivasertib2 presentations2 brandsL01EX27
- DacarbazineAlkylating Drug2 presentationsL01AX04
- ToremifeneOrphanEstrogen Agonist/Antagonist2 presentations2 brandsL02BA02
- CarfilzomibOrphanProteasome Inhibitor1 presentation2 brandsL01XX45
- AsciminibOrphan3 presentations2 brandsL01EA06
- DabrafenibOrphanKinase Inhibitor3 presentations3 brandsL01EC02
- DacomitinibOrphan3 presentations2 brandsL01EB07
- EntrectinibOrphan3 presentations2 brandsL01EX14
- EnzalutamideAndrogen Receptor Inhibitor3 presentations4 brandsL02BB04
- IsatuximabOrphanAntibodies3 presentations3 brandsL01XC38
- NiraparibOrphanPoly(ADP-Ribose) Polymerase Inhibitor3 presentations2 brandsL01XK02
- PemigatinibOrphanKinase Inhibitor3 presentations2 brandsL01EN02
- RucaparibOrphanPoly(ADP-Ribose) Polymerase Inhibitor3 presentations1 brandL01XX55
- VimseltinibOrphanKinase Inhibitor3 presentations2 brandsL01EX
- AxitinibKinase Inhibitor2 presentations3 brandsL01EK01
- DuvelisibOrphan2 presentations1 brandL01EM04
- FloxuridineAntimetabolite2 presentationsL01BC09
- LorlatinibOrphanKinase Inhibitor2 presentations2 brandsL01ED05
- OsimertinibOrphanKinase Inhibitor2 presentations2 brandsL01EB04
- PanitumumabBiologicAntibodies2 presentations2 brandsL01XC08
- QuizartinibOrphanKinase Inhibitor2 presentations2 brandsL01EX11
- RepotrectinibOrphanKinase Inhibitor2 presentations2 brandsL01EX28
- TovorafenibOrphanKinase Inhibitor2 presentations2 brandsL01EC04
- VincristineOrphanVinca Alkaloid2 presentationsL01CA02
- DaratumumabOrphanAntibodies3 presentations2 brandsL01FC01
- AlemtuzumabOrphanCD52-directed Cytolytic Antibody2 presentations3 brandsL01XC04
- CarmustineOrphanAlkylating Drug2 presentations2 brandsL01AD01
- LazertinibKinase Inhibitor2 presentations2 brandsL01EB09
- TucatinibOrphanKinase Inhibitor2 presentations2 brandsL01EH03
- EncorafenibOrphan1 presentation2 brandsL01EC03
- RegorafenibOrphanKinase Inhibitor1 presentation2 brandsL01EX05
- Abiraterone and NiraparibCytochrome P450 17A1 Inhibitor2 presentations1 brandL01
- AcalabrutinibOrphanKinase Inhibitor2 presentations2 brandsL01EL02
- Apalutamide2 presentations2 brandsL02BB05
- AtezolizumabOrphanAntibodies2 presentations2 brandsL01FF05
- Brexucabtagene autoleucelOrphan2 presentations2 brandsL01X
- CapmatinibOrphanKinase Inhibitor2 presentations2 brandsL01EX17
- CetuximabOrphanEpidermal Growth Factor Receptor Antagonist2 presentations2 brandsL01FE01
- DaraxonrasibOrphan2 presentations1 brandL01XX
- DurvalumabOrphanAntibodies2 presentations2 brandsL01FF03
- ElacestrantEstrogen Receptor Antagonist2 presentations1 brandL02BA
- ElotuzumabOrphanAntibodies2 presentations2 brandsL01FX08
- EnasidenibOrphanIsocitrate Dehydrogenase 2 Inhibitor2 presentations1 brandL01XX59
- EpcoritamabOrphanBispecific CD20-directed CD3 T Cell Engager2 presentations2 brandsL01FX27
- EpirubicinOrphanAnthracycline Topoisomerase Inhibitor2 presentations1 brandL01DB03
- Fruquintinib2 presentations2 brandsL01EK
- GlasdegibOrphanHedgehog Pathway Inhibitor2 presentations2 brandsL01XX63
- GlofitamabBiologicBispecific CD20-directed CD3 T Cell Engager2 presentations2 brandsL01FX28
- GoserelinGonadotropin Releasing Hormone Receptor Agonist2 presentations1 brandL02AE03
- IdelalisibOrphanKinase Inhibitor2 presentations2 brandsL01XX47
- ImetelstatOrphanOligonucleotide Telomerase Inhibitor2 presentations2 brandsL01XX80
- IpilimumabOrphanCTLA-4-directed Blocking Antibody2 presentations2 brandsL01FX04
- Ixabepilone2 presentations1 brandL01DC04
- MelphalanOrphanAlkylating Drug2 presentations2 brandsL01AA03
- NirogacestatOrphanGamma Secretase Inhibitor2 presentations2 brandsL01XX81
- PirtobrutinibOrphanKinase Inhibitor2 presentations2 brandsL01
- Polatuzumab vedotinOrphan2 presentations2 brandsL01FX14
- RamucirumabOrphanVascular Endothelial Growth Factor Receptor 2 Antagonist2 presentations2 brandsL01FG02
- RomidepsinOrphanHistone Deacetylase Inhibitor2 presentations1 brandL01XX39
- Talimogene laherparepvecBiologic2 presentations2 brandsL01XL02
- TalquetamabOrphan2 presentations2 brandsL01FX29
- TeclistamabOrphan2 presentations1 brandL01FX24
- TisagenlecleucelOrphanAutologous2 presentations2 brandsL01XL04
- TislelizumabOrphanProgrammed Death Receptor-1 Blocking Antibody2 presentations2 brandsL01FF09
- TivozanibKinase Inhibitor2 presentations2 brandsL01EK03
- TrabectedinOrphanAlkylating Drug2 presentations4 brandsL01CX01
- TremelimumabOrphanCTLA-4-directed Blocking Antibody2 presentations2 brandsL01FX20
- ValrubicinOrphan2 presentations1 brandL01DB09
- VandetanibOrphanKinase Inhibitor2 presentations2 brandsL01XE12
- VorasidenibOrphanIsocitrate Dehydrogenase 1 Inhibitor2 presentations2 brandsL01XM04
- ZanubrutinibOrphanKinase Inhibitor2 presentations2 brandsL01EL03
- FutibatinibOrphanKinase Inhibitor1 presentation2 brandsL01EN04
- Idecabtagene vicleucelOrphan1 presentation2 brandsL01
- MiltefosineOrphanAntileishmanial1 presentation1 brandL01XX09
- MitotaneCytochrome P450 3A4 Inducers1 presentation1 brandL01XX23
- NeratinibKinase Inhibitor1 presentation2 brandsL01EH02
- PralsetinibOrphanKinase Inhibitor1 presentation1 brandL01EX23
- RibociclibKinase Inhibitor1 presentation2 brandsL01EF02
- AdagrasibOrphan1 presentation2 brandsL01XX77
- BinimetinibOrphan1 presentation2 brandsL01EE03
- BlinatumomabOrphan1 presentation2 brandsL01FX07
- CabozantinibOrphan1 presentation3 brandsL01EX07
- Ciltacabtagene autoleucelOrphan1 presentation2 brandsL01XL05
- Cytarabine and DaunorubicinOrphanAnthracycline Topoisomerase Inhibitor1 presentation2 brandsL01XY01
- Darolutamide1 presentation2 brandsL02BB
- Degarelix1 presentation3 brandsL02BX02
- Enfortumab vedotinBiologic1 presentation2 brandsL01FX13
- FlutamideAndrogen Receptor Inhibitor1 presentation1 brandL02BB01
- GilteritinibOrphan1 presentation2 brandsL01EX13
- ImlunestrantEstrogen Receptor Antagonist1 presentation2 brandsL02BA
- MidostaurinOrphanKinase Inhibitor1 presentation1 brandL01XE39
- Nadofaragene firadenovecBiologic1 presentation2 brandsL01XL10
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
- PexidartinibOrphanKinase Inhibitor1 presentation1 brandL01XE
- SonidegibHedgehog Pathway Inhibitor1 presentation1 brandL01XJ02
- TafasitamabOrphan1 presentation2 brandsL01FX12
- TarlatamabOrphan1 presentation2 brandsL01FX33
- TepotinibOrphanKinase Inhibitor1 presentation2 brandsL01EX21
- Trastuzumab emtansineBiologic1 presentation2 brandsL01FD03
- TreosulfanOrphan1 presentation2 brandsL01AB02
- ZolbetuximabOrphanClaudin 18.2-directed Cytolytic Antibody1 presentation2 brandsL01FX31
- AlectinibOrphanKinase Inhibitor1 presentation2 brandsL01ED03
- AlitretinoinOrphanRetinoid1 presentation1 brandD11AH04
- AmivantamabBiologic1 presentation1 brandL01FX18
- AsparaginaseBiologicAsparagine-specific Enzyme1 presentation2 brandsL01XX02
- AvelumabOrphanAntibodies1 presentation2 brandsL01FF04
- Axicabtagene ciloleucelOrphanAutologous1 presentation2 brandsL01XX70
- Belantamab mafodotinOrphan1 presentation2 brandsL01FX15
- BelinostatOrphanHistone Deacetylase Inhibitor1 presentation1 brandL01XH04
- BelzutifanOrphanHypoxia-inducible Factor Inhibitor1 presentation1 brandL01XX74
- Brentuximab vedotinOrphanCD30-directed Immunoconjugate1 presentation2 brandsL01FX05
- Cabazitaxel1 presentation3 brandsL01CD04
- Camizestrant1 presentation2 brandsL02BA05
- Cedazuridine and DecitabineOrphanNucleoside Metabolic Inhibitor1 presentation2 brandsL01BC58
- CemiplimabBiologic1 presentation2 brandsL01XC33
- CeritinibOrphanKinase Inhibitor1 presentation2 brandsL01XE28
- ChlorambucilAlkylating Drug1 presentation1 brandL01AA02
- CobimetinibOrphanKinase Inhibitor1 presentation2 brandsL01EE02
- Datopotamab deruxtecanBiologic1 presentation2 brandsL01FX35
- Denileukin diftitoxOrphanCD25-directed Cytotoxin1 presentation1 brandL01XX29
- DinutuximabOrphanGlycolipid Disialoganglioside-directed Antibody1 presentation1 brandL01FX06
- DostarlimabBiologicProgrammed Death Receptor-1 Blocking Antibody1 presentation2 brandsL01FF07
- EflornithineOrphanAntiprotozoal1 presentation2 brandsD11AX
- FedratinibOrphan1 presentation2 brandsL01EJ02
- Gemtuzumab ozogamicinOrphanCD33-directed Immunoconjugate1 presentation2 brandsL01FX02
- HistrelinOrphanGonadotropin Releasing Hormone Receptor Agonist1 presentation1 brandL02AE05
- Inotuzumab ozogamicinOrphanCD22-directed Immunoconjugate1 presentation2 brandsL01FB01
- IvosidenibOrphanIsocitrate Dehydrogenase 1 Inhibitor1 presentation2 brandsL01XM02
- LifileucelBiologic1 presentation1 brandL01XL11
- Lisocabtagene maraleucelBiologic1 presentation2 brandsL01XL08
- Loncastuximab tesirineOrphan1 presentation2 brandsL01FX22
- LurbinectedinOrphanAlkylating Drug1 presentation2 brandsL01XX69
- MechlorethamineOrphanAlkylating Drug1 presentation2 brandsL01AA05
- Mirvetuximab soravtansineOrphan1 presentation2 brandsL01FX26
- MogamulizumabOrphanAntibodies1 presentation2 brandsL01FX09
- NarsoplimabOrphan1 presentation1 brandL01FX
- NilutamideAndrogen Receptor Inhibitor1 presentationL02BB02
- Nivolumab and RelatlimabOrphanLymphocyte Activation Gene-3 Blocker1 presentation2 brandsL01FY02
- Obecabtagene autoleucelBiologic1 presentation1 brandL01XL
- ObinutuzumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA03
- OfatumumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA02
- OntruzantBiologic1 presentationL01XC03
- PegaspargaseOrphanAsparagine-specific Enzyme1 presentation2 brandsL01XX24
- PentostatinOrphanNucleoside Metabolic Inhibitor1 presentation1 brandL01XX08
Conditions
AIDS-related Kaposi's sarcomaActinic keratosisAcute leukemiaAcute myeloid leukemiaAcute promyelocytic leukemiaAdenomyosisAdrenal cortex cancerAdrenal gland cancerAlveolar rhabdomyosarcomaAmelanotic melanomaAmpulla of Vater cancerAmyloidosisAnal carcinomaAnal squamous cell carcinomaAnaplastic astrocytomaAnaplastic astrocytoma of adultAnaplastic large-cell lymphomaAnaplastic thyroid cancerAngiomyolipomaAnorexiaAntiMOG associated encephalomyelitisAppendix cancerAutoimmune hemolytic anemiaAutoimmune thrombocytopenic purpuraB-cell lymphomaBasal-cell carcinoma of the skinBellini duct carcinomaBenign mesotheliomaBenign neoplasm of brainBenign pleural mesotheliomaBile duct carcinomaBladder cancerBladder urothelial carcinomaBone marrow diseaseBone sarcomaBrain cancerBreast cancerBreast carcinomaBronchus carcinomaBullous pemphigoid
Country notes
Import rules differ by country, for example permits for unregistered medicines or named-patient routes. Each country guide explains who applies, the documents needed and typical timelines.
All import guidesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Sourcing Oncology medicines?
Add the molecules you need to one request. We check each country's import rules before we quote.